Latest In vitro fertilisation Stories
The differing approaches toward infertility treatments between the US and Europe may be responsible for the enormous discrepancy in pregnancy rates. New York, NY (PRWEB) February 06, 2012 Recent reports of plateauing IVF pregnancy rates in Europe are in stark contrast to still-rising rates in the US, according to Norbert Gleicher, M.D., a prominent fertility expert and Medical Director of the Center for Human Reproduction (CHR) in New York City. Behind this difference may be a fundamental...
MENLO PARK, Calif., Feb. 2, 2012 /PRNewswire/ -- Auxogyn, Inc., a privately-held company focused on advancing women's reproductive health, today announced the close of the final tranche of its Series A financing, bringing the total funding to $20 million. The initial tranche was placed in May 2010, and investors in the round include Kleiner Perkins Caufield and Byers, TPG Biotech and Merck Serono Ventures. "Over the course of the last year, we have executed an aggressive...
"Men Having Babies" - a annual Surrogacy Seminar and Exop in NY since 2005 - makes a debut in Europe on April 29, 2012 - Part of four-day LGBT families gathering near Barcelona, Spain. (PRWEB) January 30, 2012 The Network of European LGBT Family Associations (NELFA) will host the first "Men Having Babies - Europe" Surrogacy Seminar and Gay Parenting Expo on April 29, 2012. It will take place in Lloret de Mar, near Barcelona, Spain, as part of a 4-day conference and family...
BOSTON, Jan. 25, 2012 /PRNewswire/ -- Boston IVF, a leading medical practice providing specialized infertility treatment since 1986, today announced it has introduced the first needle-free saliva test that will replace daily blood tests needed to monitor infertility treatment. Following nearly two years of research, Boston IVF has proven that the hormone estradiol, traditionally measured in the blood, can also be accurately measured in saliva, virtually eliminating the...
Approval of infertility device launches INVO into broad Brazilian market Scottsdale, AZ (PRWEB) January 21, 2012 QualityStocks would like to highlight INVO Bioscience, a publicly traded medical device company focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. The company's lead product, the INVOcell, is a novel medical device used in infertility treatment that enables egg fertilization and early embryo development. In the company’s...
Researchers have determined that babies with three biological parents could be a reality within three years by using a new IVF technique. The Wellcome Trust and Newcastle University report that they have secured new funding to develop the treatment, which could prevent genetic conditions affecting the heart, muscle or brain being passed on to children and future generations. The method has been seen as controversial because it involves transferring the parents' DNA into a donor egg,...
BEVERLY, Mass., Jan. 20, 2012 /PRNewswire/ -- INVO Bioscience, Inc. (OTC BB: IVOB), a medical device company focused on treatment options for patients diagnosed with infertility, today announced that the National Health Surveillance Agency (ANVISA) in Brazil has granted approval of the INVOcell for use as a Class II device. This approval allows the INVOcell to be sold to millions of infertile couples in Brazil and marks a major milestone in the history of the company. The approval...
A new British study of fertility treatments found that women who receive three or more embryos during in-vitro fertilization treatments have no greater chance of having a baby than those who get just two embryos. The researchers concluded that transferring three or more embryos "should no longer be supported in women of any age". Women undergoing IVF treatment are frequently implanted with three or more embryos to maximize the odds of at least one developing into a healthy baby. ...
Reports new study in Reproductive BioMedicine Online Elsevier, a world-leading provider of scientific, technical and medical information products and services today announced the publication of an article in the December issue of Reproductive BioMedicine Online (www.rbmonline.com) about miscarriage rates following IVF treatment with frozen thawed embryos which may revolutionize clinical and laboratory practice. As the practice of freezing and transferring 'surplus' embryos widens...
The number of twins born to U.S. women has soared over the past thirty years, primarily due to test-tube babies and women waiting to have children until their 30s, when the chances of having twins increase, according to a report released on Wednesday by the U.S. Centers for Disease Control and Prevention. The twin birth rate climbed 76 percent from 1980, when 1 of every 53 births was a twin delivery, to 2009, when 1 out of every 30 births were twins. "When people say it seems like you...
